Uploaded May 2025 | Updated September 2026, 2 weeks ago
Welcome to another insightful episode of #ExpertTalk by EverythingALS!
In this EverythingALS expert session, Dr. Sean E. Smith, MD, MPHS, a board-certified physiatrist at the ALS Center, Washington University School of Medicine in St. Louis, and Dr. Beth Hughes, a board-certified neurologic clinical specialist and Assistant Professor at the Washington University Program in Physical Therapy, provide an in-depth analysis of Tofersen's mechanism of action, clinical trial outcomes, and its integration with neuromuscular rehabilitation strategies. They emphasize the importance of a multidisciplinary approach to ALS treatment, combining pharmacological interventions with physical therapy to optimize patient outcomes.
Timestamps:
00:52:00 – Question: Should neurofilament be a standard test for all ALS patients?
00:56:50 – Question: Has speech returned for any pALS with SOD1 or FUS mutations after treatment?
01:02:18 – Discussion: Italian EAP data on Tofersen and neuroinflammation.
01:06:37 – Question: Cardiovascular assessment and exercise prescription in ALS.
01:08:58 – Question: Broader implications of Tofersen for other forms of ALS.
01:18:44 – Question: Are rehab study patients only from Wash U or also from other hospitals like Mass General?
01:31:57 – Case: A patient with TBK1 mutation and rehab program applicability.
01:40:54 – Question: Can non-gene mutation patients choose rehab at their discretion?
01:45:39 – Question: Could Tofersen be used prophylactically?
01:47:04–01:48:57 – Shared Resources: Links to ALS PT resources and recommendations for working with trained therapists.
Follow EverythingALS:
► Website: everythingals.org
► Twitter: https://x.com/everything_als
► LinkedIn: linkedin.com/everythingals
► Facebook: facebook.com/EverythingALS
► Subscribe for more Expert Talks: youtube.com/c/everythingals
#ExpertTalk #ALS #Tofersen #SOD1ALS #NeuromuscularRehabilitation #ALSResearch #EverythingALS #NeurodegenerativeDisease #PhysicalTherapy #ALSRecovery #ClinicalTrials #ALSCommunity #ALSAdvocacy #MotorNeuronDisease #ALSUpdates #ALSExperts
If you’re interested in the latest developments in ALS research and treatment, hit the like button, subscribe, and turn on notifications for future updates. Share this video with others who may benefit from this essential information.
Welcome to another insightful episode of #ExpertTalk by EverythingALS!
In this EverythingALS expert session, Dr. Sean E. Smith, MD, MPHS, a board-certified physiatrist at the ALS Center, Washington University School of Medicine in St. Louis, and Dr. Beth Hughes, a board-certified neurologic clinical specialist and Assistant Professor at the Washington University Program in Physical Therapy, provide an in-depth analysis of Tofersen's mechanism of action, clinical trial outcomes, and its integration with neuromuscular rehabilitation strategies. They emphasize the importance of a multidisciplinary approach to ALS treatment, combining pharmacological interventions with physical therapy to optimize patient outcomes.
Timestamps:
00:52:00 – Question: Should neurofilament be a standard test for all ALS patients?
00:56:50 – Question: Has speech returned for any pALS with SOD1 or FUS mutations after treatment?
01:02:18 – Discussion: Italian EAP data on Tofersen and neuroinflammation.
01:06:37 – Question: Cardiovascular assessment and exercise prescription in ALS.
01:08:58 – Question: Broader implications of Tofersen for other forms of ALS.
01:18:44 – Question: Are rehab study patients only from Wash U or also from other hospitals like Mass General?
01:31:57 – Case: A patient with TBK1 mutation and rehab program applicability.
01:40:54 – Question: Can non-gene mutation patients choose rehab at their discretion?
01:45:39 – Question: Could Tofersen be used prophylactically?
01:47:04–01:48:57 – Shared Resources: Links to ALS PT resources and recommendations for working with trained therapists.
Follow EverythingALS:
► Website: everythingals.org
► Twitter: https://x.com/everything_als
► LinkedIn: linkedin.com/everythingals
► Facebook: facebook.com/EverythingALS
► Subscribe for more Expert Talks: youtube.com/c/everythingals
#ExpertTalk #ALS #Tofersen #SOD1ALS #NeuromuscularRehabilitation #ALSResearch #EverythingALS #NeurodegenerativeDisease #PhysicalTherapy #ALSRecovery #ClinicalTrials #ALSCommunity #ALSAdvocacy #MotorNeuronDisease #ALSUpdates #ALSExperts
If you’re interested in the latest developments in ALS research and treatment, hit the like button, subscribe, and turn on notifications for future updates. Share this video with others who may benefit from this essential information.
